DOI QR코드

DOI QR Code

Anti-Inflammatory Effects of Prunus mume Mixture in Colitis Induced by Dextran Sodium Sulfate

매실 혼합물이 DSS로 유도된 염증성 장질환 동물모델의 면역조절에 미치는 활성

  • Jin, Hai-Lan (College of Biomedical & Health Science, Department of Applied Biochemistry, Konkuk University) ;
  • Lee, Bo-Ram (College of Biomedical & Health Science, Department of Applied Biochemistry, Konkuk University) ;
  • Lim, Kyung-Jik (Chungju High School) ;
  • Debnath, Trishna (College of Biomedical & Health Science, Department of Applied Biochemistry, Konkuk University) ;
  • Shin, Heung-Mook (Department of Physiology, Collage of Oriental Medicine, Dongguk University) ;
  • Lim, Beong-Ou (College of Biomedical & Health Science, Department of Applied Biochemistry, Konkuk University)
  • 김해란 (건국대학교 충주캠퍼스 의료생명대학 응용생명과학과) ;
  • 이보람 (건국대학교 충주캠퍼스 의료생명대학 응용생명과학과) ;
  • 임경직 (충주 고등학교) ;
  • ;
  • 신흥묵 (동국대학교 한의대 생리학과) ;
  • 임병우 (건국대학교 충주캠퍼스 의료생명대학 응용생명과학과)
  • Received : 2010.07.30
  • Accepted : 2011.02.11
  • Published : 2011.02.28

Abstract

This study was conducted to investigate the anti-inflammatory effects of Pruns mume, Schisandra chinensis, Chaenomeles sinensis-- Prunus mume mixtrue (PM) treatment on colitis induced in mice by dextran sodium sulfate (DSS) treatment. A total of 25 male BALB/c mice (average weight $20.7\;{\pm}\; 1.6 \;g$) were divided into 5 treatment groups and fed a commercial diet (A), PM administration (B), commercial diet + induced colitis by DSS (C), PM administration + induced colitis by DSS (D) and sulfasalazine + induced colitis by DSS (E). We found that PM treatment (D) and sulfasalazine (E) decreased the expression of $TNF-{\alpha}$ and COX-2 compared to the DSS-induced colitis group (C). The expression of IL-4, STAT6, $IFN-{\gamma}$, STAT1 was decreased in group D and group E compared to the colitis group (C), COX-2 and STAT1 were more decreased in group D. The serum IgE levels decreased in the PM treatment groups (C and D) compared to the non-PM treatment groups (A and B) although there was no significant difference between the PM treatment groups. It is notable that a therapeutic application of the PM extracts ameliorated DSS-induced colitis in mice.

Keywords

References

  1. Balkwill F. (2009). Tumor necrosis factor and cancer. Nature. 9:361-371.
  2. Blumberg RS, Saubermann LJ and Strober W. (1999). Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Current Opinion in Immunology. 11:648-656. https://doi.org/10.1016/S0952-7915(99)00032-1
  3. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS and Gordon S. (2003). Dectin-1 mediates the biological effects of beta-glucans. Journal of Experimental Medicine. 197:1119-1124. https://doi.org/10.1084/jem.20021890
  4. Burnette WN. (1981). "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radio- graphic detection with antibody and radioiodinated protein A. Analytical Biochemistry. 112:195-203. https://doi.org/10.1016/0003-2697(81)90281-5
  5. Cher DJ and Mosmann TR. (1987). Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. Journal of Immunology. 138:3688-3694.
  6. Chun W, Bamba T and Hosoda S. (1989). Effect of pectin, a soluble dietary fiber, on functional and morphological parameters of the small intestine in rats. Digestion. 42:22-29. https://doi.org/10.1159/000199821
  7. Dongowski G, Lorenz A and Proll J. (2002). The degree of methylation influences the degradation of pectin in the intestinal tract of rats and in vitro. Journal of Nutrition. 132:1935-1944. https://doi.org/10.1093/jn/132.7.1935
  8. East L and Isacke CM. (2002). The mannose receptor family. Biochimica et Biophysica Acta. 1572:364-386. https://doi.org/10.1016/S0304-4165(02)00319-7
  9. Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE and Buchler MW. (2000). Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency. Digestion. 62:240-248. https://doi.org/10.1159/000007822
  10. Fiocchi C. (1998). Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology. 115:182-205. https://doi.org/10.1016/S0016-5085(98)70381-6
  11. Forbes E, Murase T, Yang M, Matthaei KI, LEE JJ, Lee NA, Foster PS and Hogan SP. (2004). Immunopathogenesis of experimental ulcerative colitis in mediated by eosinophil peroxidase. Journal of Immunology. 172:5664-5675. https://doi.org/10.4049/jimmunol.172.9.5664
  12. Gauchat JF, Gascan H, Roncarolo MG, Rousset F, Pene H and De Vries JE. (1991). Regulation of human IgE synthesis: the role of CD4+ and CD8+ T-cells and the inhibitory effects of interferon-alpha. European Respiratory Journal-Supplements. 4:31-38.
  13. Hampe J, Heymann K, Kruis W, Raedler A, Folsch UR and Schreiber S. (2000). Anticipation in inflammatory bowel disease: a phenomenon caused by an accumulation of confounders. American Journal of Medical Genetics. 92:178-183. https://doi.org/10.1002/(SICI)1096-8628(20000529)92:3<178::AID-AJMG4>3.0.CO;2-P
  14. Holdsworth SR, Kitching AR and Tipping PG. (1999). Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney International. 55:1198-1216. https://doi.org/10.1046/j.1523-1755.1999.00369.x
  15. Inngjerdingen KT, Debes SC, Inngierdingen M, Hokputsa S, Harding SE, Rolstad B, Michaelsen TE, Diallo D and Paulsen BS. (2005). Bioactive pectic polysaccharides from Glinus oppositifolius (L.) Aug. DC., a Malian medicinal plant, isolation and partial characterization. Journal of Ethnopharmacology. 101:204-214. https://doi.org/10.1016/j.jep.2005.04.021
  16. Isaacs KL, Sartor RB and Haskill S. (1992). Cytokine messenger RNA profiles in inflammatory bowel disease mucosa derected by polymerase chain reaction amplification. Gastroenterology. 103:1587-1595. https://doi.org/10.1016/0016-5085(92)91182-4
  17. James SP and Klapproth JM. (1996). Major pathways of mucosal immunity and infla-mmation: cell activation, cytokine production and the role of bacterial factors. Alimentary Pharmacology & Therapeutics. 10:1-9. https://doi.org/10.1046/j.1365-2036.1996.22164000.x
  18. Kong JM, Chia LS, Goh NK, Chia TF and Brouillard R. (2003). Analysis and biological activities of anthocyanins. Phytochemistry. 64:923-933. https://doi.org/10.1016/S0031-9422(03)00438-2
  19. Levine AD and Fiocchi C. (2000). Immunology of inflammatory bowel disease. Current Opinion in Immunology. 16:306-309.
  20. Lim BO, Jolly CA, Zaman K and Fernandes G. (2000). Dietary (n-6) and (n-3) fatty acids and energy restriction modulate mesenteric lymph node lymphocyte function in autoimmuneprone (NZBxNZW) F1 mice. Journal of Nutrition. 130:1657-1664. https://doi.org/10.1093/jn/130.7.1657
  21. Lim BO. (2003). Effects of wogonin, wogonoside, and 3,5,7,2',6'- pentahydroxy-flavone on chemical mediator production in peritoneal exduate cells and immunoglobulin E of rat mesenteric lymph node lymphocytes. Journal of Ethnopharmacology. 84:23-29. https://doi.org/10.1016/S0378-8741(02)00257-X
  22. Liu L, Guo Z, Lv Z, Sun Y, Cao W, Zhang R, Liu Z, Li C, Cao S and Mei Q. (2008). The beneficial effect of Rheum tanguticm polysaccharide on protecting against diarrhea, colonic inflammation and ulceration in rats with TNBS-induced colitis: The role of macrophage mannose recptor in inflammation and immune response. International Immunopharmacology. 8:1481-1492. https://doi.org/10.1016/j.intimp.2008.04.013
  23. MacDonald TT, Hutchings P, Choy MY, Murch S and Cooke A. (1990). Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intesitine. Clinical & Experrimental Immunology. 81:301-305.
  24. Mahida YR. (1999). The key role of cytokine in immunopathogenesis of inflammatory bowel disease. Inflammation Bowel Disease. 6:21-33.
  25. Mori T, Irie Y, Nishimura SI, Tokura S, Matsuura M, Okumura M, Kadosawa T and Fujinaga T. (1998). Endothelial cell responses to chitin and its derivatives. Journal of Biomedical Materials Research. 43:469-472. https://doi.org/10.1002/(SICI)1097-4636(199824)43:4<469::AID-JBM15>3.0.CO;2-9
  26. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA and MacDonald TT. (1991). Serum concentrations of tumors necrosis factor a in childhood chronic inflammatory bowel disease. Gut. 32:913-917. https://doi.org/10.1136/gut.32.8.913
  27. Nergard CS, Matsumoto T, Inngjerdingen M, Inngjerdingen K, Hokputsa S, Harding SE, Michaelsen TE, Diallo D, Kiyohara H, Paulsen BS and Yamada H. (2005). Structural and immunological studies of a pectin and a pectic arabinogalactan from Vernonia kotschyana Sch. Bip. Ex Walp. (Asteraceae). Carbohydrate Research. 17:115-130.
  28. Pene J, Rousset F, Briere F, Chretien J, Wideman J, Bonnefoy JY and De Vries JE. (1998). Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. European Journal of Immunology. 18:929-935.
  29. Reiko Sawai, Kazumichi Kuroda, Toshikatsu Shibata, Rieko Gomyou, Kenji Osawa and Kazufumi Shimizu. (2008). Antiinfluenza virus activity of Chaenomeles sinensis. Journal of Ethnopharmacology. 118:108-112. https://doi.org/10.1016/j.jep.2008.03.013
  30. Sartor RB. (1994). Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology. 106: 533-539. https://doi.org/10.1016/0016-5085(94)90614-9
  31. Schreiber S and Hampe J. (2000). Genomics and inflammatory bowel disease. Current Opinion in Immunology. 16:297-305.
  32. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD and Raedier A. (1995). Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology. 108:21-33. https://doi.org/10.1016/0016-5085(95)90004-7
  33. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish ED, Rennick DM and Sartor RB. (1998). Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infection and Immunity. 66:5224-5231.
  34. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA and Strom TB. (1992). Tumor necrosis $factor-{\alpha},\;interleukin-1{\beta},$ and interleukin- 6 expression in inflammatory bowel disease. Digestive Diseases and Sciences. 37: 818-826. https://doi.org/10.1007/BF01300378
  35. Werner T and Haller D. (2007). Intestinal epithelial cell signaling and chronic inflammation: From the proteome to specific molecular mechanisms. Mutation Research. 622:42-57. https://doi.org/10.1016/j.mrfmmm.2007.05.010
  36. Wei X, Gong J, Zhu J, Wang P, Li N, Zhu W and Li J. (2008). The suppressive effect of triptolide on chronic colitis and $TNF-{\alpha}/TNFR2$ signal pathway in interleukin-10 deficient mice. Clinical Immunology. 129:211-218. https://doi.org/10.1016/j.clim.2008.07.018
  37. Wood PJ, Braaten JT, Scott FW, Riedel KD, Wolynetz MS and Collins MW. (1994). Effect of dose and modifications of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. British Journal of Nutrition. 72:731-743. https://doi.org/10.1079/BJN19940075
  38. Wu GJ and Tsai GJ. (2004). Cellulase degradation of shrimp chitosan for the preparation of a water-soluble hydrolysate with immunoactivity. Fisheries Science. 70:1113-1120. https://doi.org/10.1111/j.1444-2906.2004.00912.x
  39. Yamada K, Pham H, Yoshimura K, Taniguchi S, Lim BO and Sugano M. (1996). Effect of unsaturated fatty acids and antioxidants on immunoglobulin production by mesenteric lymph node lymphocytes of Sprague-Dawley rats. Journal of Biochemistry. 120:138-144. https://doi.org/10.1093/oxfordjournals.jbchem.a021375
  40. Ye MB and Lim BO. (2010). Dietary pectin regulates the levels of inflammatory cytokines and immunoglobulins in interleukin- 10 knockout mice. Journal of Agricultural and Food Chemistry. 58(21):11281-11286. https://doi.org/10.1021/jf103262s
  41. Yoshida K, Sato Y, Okyno R, Kameda K, Isobe M and Kondo T. (1996). Structural analysis and measurement of anthocyanins from colored seed coats of vigna, phaseous, and glycine legumes. Bioscience, Biotechnology, Biochemistry. 60:589-593. https://doi.org/10.1271/bbb.60.589

Cited by

  1. Natural Product-Derived Drugs for the Treatment of Inflammatory Bowel Diseases vol.12, pp.2, 2014, https://doi.org/10.5217/ir.2014.12.2.103
  2. Natural Products as a Source of Anti-Inflammatory Agents Associated with Inflammatory Bowel Disease vol.18, pp.6, 2013, https://doi.org/10.3390/molecules18067253
  3. Biological Activity Review of Mume Fructus and Processed Mume Fructus vol.31, pp.3, 2016, https://doi.org/10.6116/kjh.2016.31.3.59.
  4. Fructus mumeEthanol Extract Prevents Inflammation and Normalizes the Septohippocampal Cholinergic System in a Rat Model of Chronic Cerebral Hypoperfusion vol.19, pp.2, 2016, https://doi.org/10.1089/jmf.2015.3512
  5. Purification and characterization of a novel peptide with inhibitory effects on colitis induced mice by dextran sulfate sodium from enzymatic hydrolysates of Crassostrea gigas vol.33, pp.4, 2012, https://doi.org/10.1016/j.fsi.2012.08.017
  6. Inhibitory Effects of Angelicae Dahuricae Radix Extract on COPD induced by Cigarette Smoke Condensate and Lipopolysaccharide in Mice vol.19, pp.5, 2011, https://doi.org/10.7783/KJMCS.2011.19.5.380
  7. Study on the Anti-inflammatory Effect of Kaempferol and Kaempferol Rhamnosides Isolated from Hibiscus cannabinus L. vol.19, pp.6, 2011, https://doi.org/10.7783/KJMCS.2011.19.6.426
  8. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends vol.24, pp.25, 2018, https://doi.org/10.3748/wjg.v24.i25.2673